Highlights Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 03:23:30 2025-12-08 pm EST			5-day change	1st Jan Change
98.96 ^USD	-0.76%		-2.92%	-0.62%

09:30am	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
07:29am	Saskatchewan adds Capvaxive to publicly funded adult immunization program	RE

Highlights

Weight-loss drug developers line up to tap lucrative market as competition heats up	09:30am	RE
Global markets live: Netflix, Visa, Airbus, Ferrovial, Leonardo…	Dec. 05
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case -- Update	Dec. 04	DJ
Halozyme Wins German Patent Injunction Blocking Merck's Subcutaneous Keytruda	Dec. 04	MT
Correction to Halozyme Granted Injunction Against Merck & Co. Article	Dec. 04	DJ
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case	Dec. 04	DJ
Halozyme wins preliminary injunction against Merck's Keytruda SC in Germany	Dec. 04	RE
Merck says Exzolt Cattle-CA1 to be available by prescription in Q1 2026	Dec. 04	RE
FDA conditionally approves topical drug for cattle against New World screwworm, fever tick	Dec. 04	RE
Trump 'garbage' rhetoric about Somalis draws cheers from administration, silence from Republicans and alarm from critics	Dec. 04	RE
Ready or Not It's Coming	Dec. 02
Sector Update: Health Care Stocks Decline Late Afternoon	Dec. 01	MT
Sector Update: Health Care Stocks Decline Monday Afternoon	Dec. 01	MT
Merck seeks up to $8 billion in US bond sale tied to Cidara deal - Bloomberg News	Dec. 01	RE
Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025	Dec. 01	CI
Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices	Nov. 26	MT
Weight-loss drug developers line up to tap lucrative market as competition heats up	Nov. 25	RE
Sector Update: Health Care Stocks Advance Premarket Monday	Nov. 24	MT
Trading on Whispers Alone	Nov. 24
Merck Urges Shareholders to Reject Deep-Discount Mini-Tender Offer	Nov. 24	MT
FDA approves Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), each with Padcev (enfortumab vedotin-ejfv)	Nov. 21	RE
FDA Approves Merck and KEYTRUDA (Pembrolizumab) and KEYTRUDA QLEX (Pembrolizumab and Berahyaluronidase Alfa-Pmph	Nov. 21	CI
Pfizer, Astellas Say FDA Approves Padcev-Keytruda Combo in Bladder Cancer	Nov. 21	MT
AnaptysBio shares tumble after legal fight with GSK over cancer drug license	Nov. 21	RE
Sector Update: Health Care Stocks Softer Late Afternoon	Nov. 20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Merck to Buy Verona Pharma for About $10B

July 09, 2025 at 12:30 pm EDT